Seth W. Slettedahl
WinnMed(US)Mayo Clinic in Florida(US)
Publications by Year
Research Areas
Esophageal Cancer Research and Treatment, Epigenetics and DNA Methylation, Genetic factors in colorectal cancer, Esophageal and GI Pathology, Cancer Genomics and Diagnostics
Most-Cited Works
- → Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer(2014)675 cited
- → Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation(2018)201 cited
- → Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer(2013)160 cited
- → Risk Factors for Intrahepatic Cholangiocarcinoma: Association Between Metformin Use and Reduced Cancer Risk(2012)148 cited
- → Efficacy and Safety of Transarterial Radioembolization Versus Chemoembolization in Patients With Hepatocellular Carcinoma(2012)141 cited
- → Factors That Affect Risk for Hepatocellular Carcinoma and Effects of Surveillance(2011)123 cited
- → Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma(2018)96 cited
- → Patellofemoral arthroplasty: outcomes and factors associated with early progression of tibiofemoral arthritis(2014)80 cited
- → Highly Discriminant Methylated DNA Markers for the Non-endoscopic Detection of Barrett's Esophagus(2018)74 cited
- → Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection(2012)69 cited